ATCC

Organoids and other advanced in vitro models are opening new possibilities for research and drug discovery. But to realize their full potential, the scientific community must address a persistent challenge: reproducibility. In a recent article published in Drug Discovery World, ATCC's Carolina Lucchesi, PhD, shares why standardized biological resources are key to driving consistency, confidence, and progress across the field. Read more: https://ow.ly/a7Bo50ZjmKx

Culture collections play a critical role in advancing reproducible science, accelerating innovation, and providing reproducible tools for the global research community. As biology becomes increasingly data-driven, trusted biological materials and the associated digital data are more important than ever. ATCC will be joining experts from across the microbial collections ecosystem at the U.S. Culture Collection Network 2026 Conference “From Preservation to Innovation: Connecting Microbial Collections to Advance Science” to discuss the future of biological resources and their impact on research and innovation. Ruth R Cheng PhD, ATCC’s President and CEO, Jonathan Jacobs PhD, Senior Director, Bioinformatics, and Victoria Knight-Connoni, Principal Scientist, Content & Accessioning, will share perspectives on how authenticated, high-quality biological resources provide the foundation for reliable AI-driven discovery and how culture collections deliver reliable tools for the scientific community. We look forward to connecting with researchers and partners from academia, industry, and government labs to explore the future of culture collections. https://ow.ly/KLlM50ZrrXs #USCCN2026 #AIinBiology #ScientificInnovation #CultureCollections #Microbiology #ATCC

Selecting the right model is critical for generating reliable, predictive research outcomes. From immortalized cell lines and primary cells to organoids and other advanced systems, each model has unique strengths—and knowing when to use them can make all the difference. Learn about the most widely used cell model types, their advantages and limitations, and how to choose the best fit for your research goals in our latest blog post: https://ow.ly/McvO50Zqbgc

Dr. Randall Kincaid highlights how ATCC played an important role in responding to the Zika crisis. Learn more about how our trusted and credible resources have led to incredible results over the years. https://ow.ly/P3jI50WJEF3

In 1925, science looked very different—limited resources, evolving standards, and fewer ways to ensure reproducible research. ATCC was founded as a non-profit organization to help change that. As science advanced, we did too, expanding facilities, scaling collections, and supporting new frontiers of discovery. Today, ATCC powers modern research at the intersection of biology and technology, supporting everything from foundational studies to cutting-edge innovation. 100 years later, we’re not just part of scientific history—we’re helping shape its future. Discover what’s next for ATCC: https://ow.ly/NV2J50Zoy4J

Join us at ADLM 2026 to explore how quantitative synthetic influenza analytical reference materials can help advance diagnostic testing and surveillance. Visit our poster to see how these safe, reliable controls support assay development, validation, and performance evaluation.

Targeted therapies have transformed treatment for EGFR-mutant non-small cell lung cancer, but for most patients, drug resistance is still a matter of when, not if. In a new byline for pharmaphorum ATCC's Fang Tian, Director of Biological Content, explores how our collaboration with the Broad Institute of MIT and Harvard produced a panel of isogenic cell lines that replicate real-world resistance mechanisms – giving researchers a faster, more systematic way to study how tumors evolve and evade treatment. Read the full piece: https://ow.ly/N3XJ50ZowpC The first three cell lines are now available on our website. https://ow.ly/q2Ev50ZowpF https://ow.ly/30ib50ZowpB https://ow.ly/Hr1350ZowpE #LungCancer #EGFR #DrugResistance #CancerResearch #Oncology #CRISPR #PrecisionMedicine

What is the greatest risk? People stealing your stuff, or being territorial? Dr. Jesse Boehm discusses the risk analysis calculation and shares why sharing your research more freely advances science and your career. By combining expertise, data, and resources, researchers can tackle complex challenges more effectively and move science forward with greater urgency. Hear the full conversation on Behind the Biology: https://ow.ly/2o0A50Zoi1f #CancerResearch #Collaboration #LifeScience #TranslationalResearch #PrecisionMedicine #ResearchInnovation #BehindTheBiology

Whether you're new to organoid culture or looking to refine your techniques, the ATCC Organoid Culture Guide serves as a valuable educational resource. Learn about organoid culture workflows, handling considerations, expansion strategies, cryopreservation methods, and troubleshooting recommendations, all in one place. Explore the guide: https://ow.ly/3w9p50Zla17 #OrganoidResearch #CellBiology #LifeSciences

Antimicrobial resistance (AMR) is one of the greatest threats to global health, making infections harder to treat. Reliable, well-characterized drug-resistant strains are critical for advancing research and developing new therapies. 🔬 Explore ATCC’s authenticated collection of drug-resistant bacteria: https://ow.ly/BxUY50ZipeQ